Publications by authors named "R Abe"
Conduction Band and Defect Engineering for the Prominent Visible-Light Responsive Photocatalysts.
Angew Chem Int Ed Engl
December 2024
Controlling trap depth is crucial to improve photocatalytic activity, but designing such crystal structures has been challenging. In this study, we discovered that in 2D materials like BiOCl and Bi4NbO8Cl, composed of interleaved [Bi2O2]2+ and Cl- slabs, the trap depth can be controlled by manipulating the slab stacking structure. In BiOCl, oxygen vacancies (VO) create deep electron traps, while chlorine vacancies (VCl) produce shallow traps.
View Article and Find Full Text PDFLoss of oligodendrocytes causes severe neurological damage. Oligodendrogenesis is the production of new oligodendrocytes throughout life and includes several developmental stages starting from oligodendrocyte precursor cells (OPCs). The GPR17-expressing cell population, an important intermediate stage in oligodendrocyte development, acts as a reservoir responding to brain injury and ischemia.
View Article and Find Full Text PDFArticle Synopsis
- This study explores the use of a post-tetanic MEP augmentation technique to improve baseline recordings during craniotomies while minimizing neuromuscular blockade (NMB).
- It involved 26 patients, maintaining a partial NMB level to achieve successful MEPs through tetanic stimulation of the median nerve before transcranial stimulation.
- The technique increased the success rate of recordings to 100% and improved response amplitudes without causing any unexpected movements, suggesting it could be an effective approach for safer craniotomy procedures.
Article Synopsis
- * In fulvestrant-resistant breast cancer cells (Ful-R), a loss of ERα and decreased levels of the transcriptional regulator FOXO3a occur, resulting in increased expression of HER2 and enhanced cell proliferation.
- * Targeting FOXO3a may offer a potential therapeutic strategy for treating HER2-positive, estrogen, and progesterone receptor-negative aggressive breast cancers that have developed resistance to fulvestrant.